La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Neurotransmitter Agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neurotoxins < Neurotransmitter Agents < Neurotransmitter Uptake Inhibitors  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000303 (2015) H. Iderberg ; A C Mccreary ; M A Varney ; M S Kleven ; W. Koek ; L. Bardin ; R. Depoortère ; M A Cenci ; A. Newman-TancrediNLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
000373 (2015) Marie Vandecasteele ; Yann-Suhan Senova ; Stéphane Palfi ; Guillaume P. Dugué[Therapeutic potential of optogenetic neuromodulation].
000854 (2012) Christian Even ; Daniel WeintraubIs depression in Parkinson's disease (PD) a specific entity?
000D13 (2008) Gilles FénelonPsychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
001062 (2003) Erwan Bezard ; Jerome Baufreton ; Geraint Owens ; Alan R. Crossman ; Hank Dudek ; Anne Taupignon ; Jonathan M. BrotchieSonic hedgehog is a neuromodulator in the adult subthalamic nucleus.
001126 (2003) E C Hirsch ; G. Orieux ; M-P Muriel ; C. Francois ; J. FegerNondopaminergic neurons in Parkinson's disease.
001229 (2001) S. Thobois ; S. Guillouet ; E. BroussolleContributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
001235 (2001) F. Chollet ; I. Loubinoux ; J. Pariente ; C. Carel ; J F Albucher ; O. Rascol ; B. Guiraud-Chaumeil[Pharmacologic modification of cerebral activity: value of functional neuroimaging].
001447 (1998) C. Toffano-Nioche ; D. Beroule ; J P TassinA functional model of some Parkinson's disease symptoms using a Guided Propagation Network.
001467 (1998) M G Murer ; G. Dziewczapolski ; L B Menalled ; M C García ; Y. Agid ; O. Gershanik ; R. Raisman-VozariChronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
001813 (1990) R. Deloncle ; O. GuillardMechanism of Alzheimer's disease: arguments for a neurotransmitter-aluminium complex implication.
001826 (1990) Y. Agid ; A M Graybiel ; M. Ruberg ; E. Hirsch ; J. Blin ; B. Dubois ; F. Javoy-AgidThe efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
001856 (1989) Y. Agid ; P. Cervera ; E. Hirsch ; F. Javoy-Agid ; S. Lehericy ; R. Raisman ; M. RubergBiochemistry of Parkinson's disease 28 years later: a critical review.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Neurotransmitter Agents" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Neurotransmitter Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Neurotransmitter Agents
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024